Festina lente! – editorial
Authors:
J. Hradec
Authors‘ workplace:
III. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
Published in:
Vnitř Lék 2012; 58(10): 719-720
Category:
Editorial
Sources
1. McAlister FA, Wiebe N, Ezekowitz JA et al. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med 2009; 150 : 784–794.
2. Böhm M, Swedberg K, Komajda M et al. SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010; 376 : 886–894.
3. McAlister FA, Wiebe N, Ezekowitz JA et al. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med 2009; 150 : 784–794.
4. Swedberg K, Komajda M, Böhm M et al. SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled trial. Lancet 2010; 376 : 875–885.
5. Böhm M, Borer J, Ford I et al. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clin Res Cardiol 2012 May 11 [Epub ahead of print].
6. Swedberg K, Komajda M, Böhm M et al. SHIFT Investigators. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: Is there an influence of beta-blocker dose? Findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study. J Am Coll Cardiol 2012; 59 : 1938–1945.
7. Špinar J, Vítovec J, Hradec J et al. Czech Society of Cardiology guidelines for the diagnosis and treatment of chronic heart failure. Cor Vasa 2012; 54: e113–e134.
8. McMurray JJ, Adamopoulos S, Anker SD et al. ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33 : 1787–1847.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2012 Issue 10
-
All articles in this issue
- Acute myocardial infarction in young adults – what is wrong? – editorial
- Less invasive cardiac surgery approaches to treat ischemic heart disease – editorial
- Visceral leishmaniasis – editorial
- Festina lente! – editorial
- Acute myocardial infarction in young patients – severe failures in the system of acute and secondary care
- Is there a relationship between inflammatory markers, oxidative stress and postoperative atrial fibrillation?
- Sarcoidosis – diagnostics, prognosis and therapy. A retrospective analysis
- Vitamin C and its physiological role with respect to the components of the immune system
- Hypoglycaemia – a phenomenon over which modern diabetology manages to prevail
- AII antagonists (candesartan and irbesartan) in the treatment of cardiovascular diseases
- Febrile pancytopenia and hepatosplenomegaly as leading symptoms of visceral leishmaniasis
- High suspicion of hearth disease gained from taking the case history must not controvert negative results of some medical examination – experience outpatient internist
- Dabigatran etexilate in clinical practice for prevention of thromboembolic events in patients with atrial fibrillation
- Effect of ivabradin on heart rate, left ventricular function a NT-proBNP concentration in patients with systolic chronic heart failure – case reports
- Diagnosis and treatment of arterial hypertension. 2012 Guidelines of the Czech Hypertension Society
- Internal Medicine
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Vitamin C and its physiological role with respect to the components of the immune system
- Sarcoidosis – diagnostics, prognosis and therapy. A retrospective analysis
- Acute myocardial infarction in young patients – severe failures in the system of acute and secondary care
- Febrile pancytopenia and hepatosplenomegaly as leading symptoms of visceral leishmaniasis